Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05440058 · ClinicalTrials.gov registry record
BIS Monitoring in Relation to Muscle Relaxant Administration
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 22
- Enrollment target
NCT05440058: Completed study, sponsored by Mayo Clinic.
NCT05440058 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05440058 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.
Primary Outcome
Parameters measured from both left and right BIS sensors. BIS monitor algorithm to process EEG information second by second and outputs a number (0-100) that corresponds with a patient's level of consciousness. A level of 0 indicates no EEG activity; a level of 100 indicates awake EEG activity.
Interventions
- DEVICE Bispectral Index (BIS) monitoring system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-08-26 |
| Est. Completion | 2022-09-20 |
What the finished NCT05440058 record still lists
NCT05440058 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Bispectral Index (BIS) monitoring system is the first listed.
NCT05440058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05440058 about?
NCT05440058 is a clinical study titled "BIS Monitoring in Relation to Muscle Relaxant Administration". The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.
What is the current status of trial NCT05440058?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2022-08-26. Estimated completion is 2022-09-20.
What interventions are being tested in trial NCT05440058?
The interventions under investigation include: Bispectral Index (BIS) monitoring system (DEVICE).
Who is sponsoring clinical trial NCT05440058?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI